Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Researchers at Australia's WEHI (Walter and Eliza Hall Institute) medical research center applied AI analysis to over 50,000 ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

For those who smoke, this long-term habit can damage parts of your eye, contributing to serious conditions such as macular ...

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...

Retinal thickness could be an early indicator of diseases such as Type 2 diabetes and dementia, according to study by a team of Australian-led international researchers on Wednesday. Researchers led ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...